| 2c9eeca2-f033-4c34-81ee-214eb79f502c | Operações de guerra | Y36 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 14103 | 1 | 2021-05-25T19:40:03.696000+00:00 | 2021-05-25T19:40:03.696000+00:00 |
| a0b4edd1-fce6-4c0b-816f-fe6b930c71bf | Operações de guerra envolvendo explosão de armamento naval | Y360 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11470 | 1 | 2021-05-25T19:40:03.644000+00:00 | 2021-05-25T19:40:03.644000+00:00 |
| f055e1c6-ba67-4d38-82fb-6813f87128db | Operações de guerra envolvendo destruição de aeronave | Y361 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11471 | 1 | 2021-05-25T19:40:03.644000+00:00 | 2021-05-25T19:40:03.644000+00:00 |
| 5b9d9b8f-6e5b-4961-b064-cde8d15eee22 | Operações de guerra envolvendo outras explosões ou fragmentos | Y362 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11472 | 1 | 2021-05-25T19:40:03.644000+00:00 | 2021-05-25T19:40:03.644000+00:00 |
| 08a2f28c-4e19-4898-b39e-6a55817342f9 | Operações de guerra envolvendo incêndio, fogo e substâncias quentes | Y363 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11473 | 1 | 2021-05-25T19:40:03.644000+00:00 | 2021-05-25T19:40:03.644000+00:00 |
| 157894e4-c723-4d56-b887-e17dee930305 | Operações de guerra envolvendo disparo de armas de fogo e de outras formas convencionais de combate | Y364 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11474 | 1 | 2021-05-25T19:40:03.644000+00:00 | 2021-05-25T19:40:03.644000+00:00 |
| 93085457-819e-4b26-ab27-c129252340ff | Operações de guerra envolvendo armamento nuclear | Y365 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11475 | 1 | 2021-05-25T19:40:03.644000+00:00 | 2021-05-25T19:40:03.644000+00:00 |
| 1604b8ed-65d1-4b73-b024-7e14fae46c6a | Operações de guerra envolvendo armas biológicas | Y366 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11476 | 1 | 2021-05-25T19:40:03.644000+00:00 | 2021-05-25T19:40:03.644000+00:00 |
| 2284fa72-83b4-4cd0-b2c7-e8cde42918d6 | Operações de guerra envolvendo armas químicas e outros meios de combate não-convencionais | Y367 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11477 | 1 | 2021-05-25T19:40:03.644000+00:00 | 2021-05-25T19:40:03.644000+00:00 |
| 7c4b9eaa-20c2-44a1-a040-4c364986af46 | Operações de guerra ocorridas após a cessação das hostilidades | Y368 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11478 | 1 | 2021-05-25T19:40:03.644000+00:00 | 2021-05-25T19:40:03.644000+00:00 |
| 02a35ab2-f2bf-49b0-9b01-4d42e9352406 | Operações de guerra não especificadas | Y369 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11479 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| a36e4468-db4c-4239-aca9-9f5e9bddcbcc | Efeitos adversos de antibióticos sistemicos | Y40 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 14104 | 1 | 2021-05-25T19:40:03.696000+00:00 | 2021-05-25T19:40:03.696000+00:00 |
| 22480af6-bdf2-46d8-91ca-21be82ae90e6 | Efeitos adversos de penicilinas | Y400 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11480 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| c95ee1e0-815c-4326-a08c-61f7d17c6c95 | Efeitos adversos de cefalosporinas e outras betalactaminas | Y401 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11481 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| 86503371-84e8-4721-b43b-575ff1f471f3 | Efeitos adversos do grupo do cloranfenicol | Y402 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11482 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| c3719588-c8ec-4949-9d15-f6a2da876e69 | Efeitos adversos de macrolídeos | Y403 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11483 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| 479327ac-0c7a-4add-be15-ceb9fe98bf04 | Efeitos adversos de tetraciclinas | Y404 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11484 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| 3b9960d4-076e-4c39-abfa-2e8004f5124e | Efeitos adversos de aminoglicosídeos | Y405 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11485 | 1 | 2021-05-25T19:40:03.645000+00:00 | 2021-05-25T19:40:03.645000+00:00 |
| 98f0e81d-8af5-4183-be8d-37f7470796e1 | Efeitos adversos de rifamicinas | Y406 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11486 | 1 | 2021-05-25T19:40:03.645000+00:00 | 2021-05-25T19:40:03.645000+00:00 |
| 488e8e61-7659-49cf-936a-ba127e3ad5b8 | Efeitos adversos de antibióticos antifúngicos administrados por via sistêmica | Y407 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11487 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| 3fde00dc-1b9b-4209-a165-8e6f698bea1f | Efeitos adversos de outros antibióticos administrados por via sistêmica | Y408 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11488 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| 141c60c3-4f76-4df9-904d-47e3614eae22 | Efeitos adversos de antibiótico sistêmico, não especificado | Y409 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11489 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| 4ad3321b-1cc1-48cb-b9a6-2bba79b5c6d9 | Efeitos adversos de outros antiinfecciosos e antiparasitários sistemicos | Y41 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 14105 | 1 | 2021-05-25T19:40:03.696000+00:00 | 2021-05-25T19:40:03.696000+00:00 |
| 62ca6d2e-38f2-47d0-aaa9-c21a219455bd | Efeitos adversos de sulfonamidas | Y410 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11490 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| b980f4d8-16de-44ac-9a9e-943e7fe4e5df | Efeitos adversos de drogas antimicobacterianas | Y411 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11491 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| 50552e33-2301-444a-ad6c-68510306c47d | Outros fatos ou eventos especificados - local não especificado | Y339 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11451 | 1 | 2021-05-25T19:40:03.644000+00:00 | 2021-05-25T19:40:03.644000+00:00 |
| f1e72b0c-cf3a-48a5-b3ee-9ada351fca77 | Intervenção legal | Y34 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 14101 | 1 | 2021-05-25T19:40:03.696000+00:00 | 2021-05-25T19:40:03.696000+00:00 |
| c700e95d-cba3-4db9-aa4f-58861cd1be93 | Fatos ou eventos não especif. e intenção ñ determ. - rua e estrada | Y344 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11456 | 1 | 2021-05-25T19:40:03.644000+00:00 | 2021-05-25T19:40:03.644000+00:00 |
| f419fd32-84c2-4784-89bd-ebec3afb0bff | Efeitos adversos de hormônios e substitutos da tireóide | Y421 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11499 | 1 | 2021-05-25T19:40:03.670000+00:00 | 2021-05-25T19:40:03.670000+00:00 |
| 8e9cb763-8922-4914-a035-6e5885eb0cf7 | Efeitos adversos de glicocorticóides e análogos sintéticos | Y420 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11498 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| 147ffce3-f3d6-43aa-bd98-167070d35538 | Efeitos adversos de anticoncepcionais [contraceptivos] orais | Y424 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11502 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| 282092e1-7e5b-4c97-8821-13883cf2dbaf | Efeitos adversos de outros estrógenos e progestágenos | Y425 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11503 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| 958358f8-ad1f-47b2-b02f-3a730c66399a | Efeitos adversos de antigonadotrofinas, antiestrógenos e antiandrógenos, não classif. em outra parte | Y426 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11504 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| e3867b1f-a0a1-48c4-98eb-3b8a259f4230 | Efeitos adversos de andrógenos e anabolizantes congêneres | Y427 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11505 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| 0809ce2d-c706-4bd4-892a-82741ab08e60 | Efeitos adversos de outros hormônios e os não especificados e seus substitutos sintéticos | Y428 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11506 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| d27ee450-1b2a-4ab4-a366-df6a7a62e2e6 | Efeitos adversos de outros antagonistas hormonais e os não especificados | Y429 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11507 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| d0aad181-06d8-42fc-bab8-4807611bb10b | Efeitos adversos de substancias de ação primáriamente sistemica | Y43 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 14107 | 1 | 2021-05-25T19:40:03.696000+00:00 | 2021-05-25T19:40:03.696000+00:00 |
| 449f1631-9061-48b3-87f5-a75df2841051 | Efeitos adversos de drogas antialérgicas e antieméticas | Y430 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11508 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| 3e79ff17-a403-4493-b6e2-cbf5164fbe59 | Efeitos adversos de produtos naturais antineoplásicos | Y432 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11510 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| b6af05e6-c5f1-4000-a318-4c838122a00b | Efeitos adversos de outras drogas antineoplásicas | Y433 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11511 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| 6c95098f-5703-42b3-ae5b-ef7e972b7c4c | Efeitos adversos de agentes imunossupressores | Y434 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11512 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| 75180c91-7877-438f-aa2a-d3fbc8080cee | Efeitos adversos de acidificantes e alcalinizantes | Y435 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11513 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| 0bc95ea4-0c09-475d-9024-f18d0074e4e3 | Efeitos adversos de enzimas, não classificadas em outra parte | Y436 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11514 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| e764ff16-a963-47a1-8e49-d9a6c03aec8d | Efeitos adversos de outras subst. farmacol. de ação primar. sistêmica, não classif. em outra parte | Y438 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11515 | 1 | 2021-05-25T19:40:03.668000+00:00 | 2021-05-25T19:40:03.668000+00:00 |
| a8289725-ad25-4125-81c4-a7bb4da4bd98 | Substancias farmacológicas que atuam primáriamente sobre os constituintes do sangue | Y44 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 14108 | 1 | 2021-05-25T19:40:03.696000+00:00 | 2021-05-25T19:40:03.696000+00:00 |
| cc3e8d4d-7c2c-45c6-8214-4d906f1f09d5 | Efeitos adversos de preparações a base de ferro e outras prepar. prescritas na anemia hipocrômica | Y440 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11517 | 1 | 2021-05-25T19:40:03.669000+00:00 | 2021-05-25T19:40:03.669000+00:00 |
| 7f11bb3d-4717-40a5-97c0-60635d4a99bd | Efeitos adversos da vitamina B12, ácido fólico e outras prep. prescritas nas anemias megaloblásticas | Y441 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11518 | 1 | 2021-05-25T19:40:03.669000+00:00 | 2021-05-25T19:40:03.669000+00:00 |
| cc4e2c81-34df-4015-b209-7582b27b9ef8 | Efeitos adversos de anticoagulantes | Y442 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11519 | 1 | 2021-05-25T19:40:03.669000+00:00 | 2021-05-25T19:40:03.669000+00:00 |
| 93548d10-f69b-4a97-8d74-ce29a1d0e6b0 | Efeitos adversos de antagonistas de anticoagulantes, vitamina k e outros coagulantes | Y443 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11520 | 1 | 2021-05-25T19:40:03.669000+00:00 | 2021-05-25T19:40:03.669000+00:00 |
| 90b88277-40b8-4a84-8c25-8c41385b30d3 | Efeitos adversos de drogas antitrombóticas [inibidores da agregação de plaquetas] | Y444 | 708dcbc4-baf1-4882-8fb6-24914a6c152e | f8641bf6-74cd-4bb9-be22-22cbb555885c | 11521 | 1 | 2021-05-25T19:40:03.669000+00:00 | 2021-05-25T19:40:03.669000+00:00 |